Becoming Acculturated

Techniques for deep dives into the microbial dark matter

Written byJeffrey M. Perkel
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

A HELPING HAND: To identify and cultivate bacteria whose growth depends on a soluble growth factor, Lewis plated bacteria from sand grains on agar (A) and isolated and streaked candidate pairs (B). The growth of KLE1104 (green) depends on KLE1011 (white), as its colonies get smaller the farther away they are from the helper cells (C). Used media from a helper strain culture is sufficient to support KLE1104 growth, indicating a growth factor is all that’s missing. A. D'ONOFRIO ET AL., CHEMISTRY & BIOLOGY, 17:254-64, 2010If you take a sample of seawater and plate it on a typical petri dish, colonies of bacteria will flourish. Each of those colonies springs from a single cell; counting those colonies provides an estimate of the number and variety of organisms in the water sample. But count the cells in that same sample directly, and you’ll find you’ve only scratched the surface.

That difference is called “The Great Plate Count Anomaly,” and it is vast. By some estimates, direct cultivation captures just 0.01 percent to 1 percent of the bacterial diversity in biological samples. The rest represents a missed opportunity of sorts—organisms whose ecologic functions and metabolic potentials researchers could glimpse, perhaps by sequencing their DNA, but never directly study. This dark matter of the microbial world could be an untapped gold mine of antibiotics, biofuels, bioremediators, and more. (See “Lost Colonies,” The Scientist, October 2015.)

In the world of microbiology, such organisms are designated uncultivable. But that label isn’t quite right, says J. Cameron Thrash, a microbiologist at the Louisiana State University in Baton Rouge; after all, these organisms grow in nature, some exceptionally successfully. “I ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies